167 filings
Page 2 of 9
8-K
84t4o z9o2fa0zycf9
19 Dec 18
Entry into a Material Definitive Agreement
4:01pm
8-K
c943w
19 Nov 18
Entry into a Material Definitive Agreement
5:20pm
8-K
wh1zr1mh9xonom7z1p
7 Nov 18
Melinta Therapeutics Reports Third Quarter 2018 Financial Results
8:27am
8-K
izkrok
5 Nov 18
Departure of Directors or Certain Officers
5:21pm
8-K
byf7hn u8ke
24 Oct 18
Melinta Therapeutics Announces Appointment of John H. Johnson as Interim Chief Executive Officer
4:59pm
8-K
82os544vt2 dz
5 Oct 18
Departure of Directors or Certain Officers
5:18pm
8-K
hfhmdofkc8urgzij xaj
2 Oct 18
Entry into a Material Definitive Agreement
4:55pm
8-K
u922e27fn89 ihuztaz
27 Sep 18
Entry into a Material Definitive Agreement
12:00am
8-K
tz3fs zd735x7b
19 Sep 18
Melinta Therapeutics Names Peter Milligan as Chief Financial Officer
9:23am
8-K
txq1lxt a48
7 Aug 18
Melinta Therapeutics Reports Second Quarter 2018 Financial Results
9:15am
8-K
u7388s
14 Jun 18
Departure of Directors or Certain Officers
12:00am
8-K/A
k0e2j 4sgqqornp1e7
8 Jun 18
Financial Statements and Exhibits
4:39pm
8-K
u84zi7
29 May 18
Melinta Therapeutics Announces Proposed Offering of Common Stock
5:18pm
8-K
yv2n xmw13w4660mgq7
8 May 18
Melinta Therapeutics Reports First Quarter 2018 Financial Results
9:48pm
8-K
zztu zr1lkziqn
27 Mar 18
Regulation FD Disclosure
12:00am
8-K
zc5q6lm1
14 Mar 18
Other Events
12:00am
8-K
e5vgw6n5
13 Mar 18
Melinta Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
12:00am
8-K/A
vrkg7m0a
10 Jan 18
Financial Statements and Exhibits
12:00am
8-K
v6xbjoefhtsbsvslrufv
9 Jan 18
Melinta Therapeutics Completes Acquisition of The Medicines Company’s
12:00am
8-K
7do1oafjs 9uzp4
3 Jan 18
Departure of Directors or Certain Officers
12:00am